Wednesday, December 24, 2025 | 12:02 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Best of BS Opinion: The mis-selling menace, Covid-19 vaccination, and more

Here's a selection of Business Standard opinion pieces for the day

vaccine, vaccination, coronavirus, covid
premium

Illustration: Binay Sinha

Rajesh Kumar New Delhi
Here's a selection of Business Standard opinion pieces for the day
 
The government announced on Tuesday that it had accepted a recommendation by the National Expert Group that vaccines approved by health regulators in the European Union, the United States, Japan, and the United Kingdom should be granted emergency use approval in India. In this context, our lead editorial notes that having eased requirements, the government’s next step must be to ensure that India’s spare vaccine capacity — it could be producing enough two-shot vaccines a year to inoculate half the world — is pressed into service.
 
After watching the